📰 Ioscience News
Page 16 - Ioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ioscience. Real-time updates on events, politics, business and more.
September 20, 2022
New York, New York--(Newsfile Corp. - September 20, 2022) - PCG Digital - Lexaria Bioscience (NASDAQ: LEXX) (NASDAQ: LEXXW) is targeting the $28 billion hypertension drug market with its innovative drug
September 19, 2022
Drug Candidate progressing to the clinic for evaluation in the treatment of 5T4-expressing tumor antigens in multiple solid tumor typesLUND, SWEDEN and SEATTLE WA / ACCESSWIRE / September 19, 2022 / Alligator
September 13, 2022
Toronto, Ontario--(Newsfile Corp. - September 13, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change
September 8, 2022
WOBURN, Mass., Sept. 08, 2022 -- Yield10 Bioscience, Inc. , an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview... | September 8, 2022
September 7, 2022
Toronto, Ontario--(Newsfile Corp. - September 7, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change
September 5, 2022
Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The "Cell Counting Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The...
September 2, 2022
KELOWNA, BC / ACCESSWIRE / September 2, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that
August 31, 2022
Toronto, Ontario--(Newsfile Corp. - August 30, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change
August 31, 2022
KELOWNA, BC / ACCESSWIRE / August 31, 2022 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce its
August 30, 2022
Toronto, Ontario--(Newsfile Corp. - August 29, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Corporation"), a regenerative medicine company aimed at developing therapeutics that change